Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 14 studies | 41% ± 22% | |
| epithelial cell | 6 studies | 30% ± 22% | |
| endothelial cell of lymphatic vessel | 6 studies | 31% ± 14% | |
| retinal ganglion cell | 4 studies | 42% ± 25% | |
| basal cell | 4 studies | 34% ± 22% | |
| GABAergic neuron | 3 studies | 40% ± 8% | |
| glutamatergic neuron | 3 studies | 46% ± 11% | |
| transit amplifying cell | 3 studies | 42% ± 28% | |
| renal principal cell | 3 studies | 22% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 100% | 3079.68 | 359 / 359 | 100% | 71.06 | 285 / 286 |
| skin | 100% | 9003.91 | 1809 / 1809 | 99% | 78.78 | 469 / 472 |
| intestine | 100% | 3196.23 | 963 / 966 | 100% | 69.88 | 525 / 527 |
| esophagus | 99% | 8335.89 | 1433 / 1445 | 100% | 97.64 | 183 / 183 |
| brain | 99% | 3105.48 | 2620 / 2642 | 100% | 61.96 | 702 / 705 |
| pancreas | 100% | 4782.45 | 328 / 328 | 98% | 31.54 | 175 / 178 |
| prostate | 97% | 2430.55 | 238 / 245 | 99% | 51.55 | 495 / 502 |
| uterus | 99% | 2593.35 | 169 / 170 | 96% | 45.68 | 441 / 459 |
| breast | 98% | 2233.35 | 448 / 459 | 94% | 31.64 | 1052 / 1118 |
| bladder | 100% | 2670.24 | 21 / 21 | 90% | 40.81 | 454 / 504 |
| lung | 85% | 1865.05 | 490 / 578 | 95% | 38.14 | 1093 / 1155 |
| thymus | 98% | 2050.52 | 639 / 653 | 70% | 13.82 | 424 / 605 |
| ovary | 57% | 809.44 | 103 / 180 | 96% | 39.31 | 412 / 430 |
| kidney | 79% | 1407.47 | 70 / 89 | 73% | 23.87 | 657 / 901 |
| adrenal gland | 75% | 1778.31 | 193 / 258 | 72% | 19.19 | 166 / 230 |
| eye | 0% | 0 | 0 / 0 | 100% | 67.79 | 80 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 59.94 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 16.58 | 1 / 1 |
| spleen | 100% | 2181.70 | 240 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 2401.82 | 1312 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 97% | 2034.47 | 1165 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 28.09 | 27 / 29 |
| heart | 78% | 1809.30 | 674 / 861 | 0% | 0 | 0 / 0 |
| liver | 16% | 277.31 | 37 / 226 | 18% | 4.17 | 72 / 406 |
| peripheral blood | 29% | 2184.16 | 269 / 929 | 0% | 0 | 0 / 0 |
| muscle | 15% | 228.24 | 124 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0042102 | Biological process | positive regulation of T cell proliferation |
| GO_1903401 | Biological process | L-lysine transmembrane transport |
| GO_0150104 | Biological process | transport across blood-brain barrier |
| GO_1903826 | Biological process | L-arginine transmembrane transport |
| GO_0015807 | Biological process | L-amino acid transport |
| GO_1903352 | Biological process | L-ornithine transmembrane transport |
| GO_0046718 | Biological process | symbiont entry into host cell |
| GO_0089718 | Biological process | amino acid import across plasma membrane |
| GO_0015822 | Biological process | ornithine transport |
| GO_0015819 | Biological process | lysine transport |
| GO_0097638 | Biological process | L-arginine import across plasma membrane |
| GO_0006865 | Biological process | amino acid transport |
| GO_1903810 | Biological process | L-histidine import across plasma membrane |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0009925 | Cellular component | basal plasma membrane |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0061459 | Molecular function | L-arginine transmembrane transporter activity |
| GO_0015171 | Molecular function | amino acid transmembrane transporter activity |
| GO_0005290 | Molecular function | L-histidine transmembrane transporter activity |
| GO_0015174 | Molecular function | basic amino acid transmembrane transporter activity |
| GO_0001618 | Molecular function | virus receptor activity |
| GO_0000064 | Molecular function | L-ornithine transmembrane transporter activity |
| GO_0015189 | Molecular function | L-lysine transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC7A1 |
| Protein name | Solute carrier family 7 (Cationic amino acid transporter, y+ system), member 1 High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter) Solute carrier family 7 member 1 |
| Synonyms | ATRC1 ERR REC1L |
| Description | FUNCTION: High-affinity, low capacity permease involved in the transport of the cationic amino acids (arginine, lysine and ornithine) in non-hepatic tissues. . |
| Accessions | ENST00000380752.10 P30825 A0A0A8K9B7 ENST00000450494.1 Q5JR49 |
